| Deanna Smith, OTR/L | |
|
150 N Miller Rd Ste 150a, Fairlawn, OH 44333-3713 | |
| (330) 867-2240 | |
| Not Available |
| Full Name | Deanna Smith |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 150 N Miller Rd Ste 150a, Fairlawn, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164190302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT011678 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deanna Smith, OTR/L 13931 Cannon Oval, North Royalton, OH 44133-4117 Ph: (440) 539-3445 | Deanna Smith, OTR/L 150 N Miller Rd Ste 150a, Fairlawn, OH 44333-3713 Ph: (330) 867-2240 |
News Archive
Provenge is one step closer to being covered by Medicare. An expert panel voted Wednesday to endorse the newly approved therapeutic vaccine for men with advanced prostate cancer.
Scientists from Germany and Italy recently demonstrated the benefits of intramuscular/intranasal heterologous prime-boost vaccination regimen against coronavirus disease 2019 (COVID-19).
TechAtlas Group has announced the release of the latest Type 1 Diabetes competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development.
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.
› Verified 9 days ago
Dr. Ryan A Domer, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 S Cleveland Massillon Rd, Fairlawn, OH 44333 Phone: 330-666-5866 | |
Brittany Stout, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd, #150a, Fairlawn, OH 44333 Phone: 330-867-2240 | |
Kelsey Moyra Washko, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Road, Suite 150a, Fairlawn, OH 44333 Phone: 216-219-0659 | |
Meredith Santiago, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 61 N Cleveland Massillon Rd, B, Fairlawn, OH 44333 Phone: 330-668-4041 Fax: 330-666-5626 | |
Madonna Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd, Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 Fax: 330-630-3198 | |
Ms. Elizabeth Grace Swope, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Baker Blvd, Suite1, Fairlawn, OH 44333 Phone: 330-865-1600 |